Entrepreneur UK's London 100: apo
apo is democratising musculoskeletal (MSK) healthcare through its innovative and holistic AI-powered digital platform.
Opinions expressed by Entrepreneur contributors are their own.
You're reading Entrepreneur United Kingdom, an international franchise of Entrepreneur Media.
Industry: Artificial Intelligence
apo is democratising musculoskeletal (MSK) healthcare through its innovative and holistic AI-powered digital platform.
In the UK alone, musculoskeletal (MSK) conditions affect over 20 million people each year, costing the NHS billions and resulting in more than 30 million lost working days annually.
apo tackles this head-on with its comprehensive digital approach, organised around four core pillars (Move, Discover, Nourish, and Unwind) each tailored to empower users with personalised physical therapy, curated educational content, nutrition guidance, and mental health support.
Founded in 2024 by Lauren Romanish, apo's mission is clear: transform how millions manage MSK pain, turning the industry's reliance on fragmented, episodic care into a seamless, continuous, and empowering user experience.
Romanish has recently been named "The UK's Most Influential Female Founder in Healthcare to Watch."
Furthermore, apo has received multiple awards and recognitions and is partnering with the National Health Service (NHS) to deliver more effective and efficient care — reducing our healthcare system's burdens and improving patient outcomes.
Building Software as a Medical Device (SaMD), apo places safety, reliability, and clinical validation at the heart of its innovation.
Unlike traditional healthcare apps, apo employs cutting-edge technology to deliver hyper personalised, interactive, and visually rich content.
apo's intuitive design and real-time analytics encourage consistent user engagement, fostering long-term behavioural change.
"apo's innovation lies in its ability to seamlessly blend clinical rigour with engaging, personalised wellness experiences. By putting sophisticated, adaptive AI directly into users' hands, we empower them not just to manage pain, but to fundamentally transform their relationship with health," says Romanish.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Piper Sandler Reaffirms Overweight Rating on Soleno (SLNO) Driven by Strong VYKAT XR Prospects
Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the 10 biotech stocks screaming a buy now. On June 17, Piper Sandler reiterated an 'Overweight' rating on the stock with a $145 price target. The bullish stance follows positive discussions with a European specialist on the company's VYKAT XR medication for Prader-Willi syndrome (PWS). A scientist in a laboratory examining a microscope in the pursuit of cell therapy discoveries. Piper Sandler consulted a UK-based pediatric endocrinologist to understand the drug better. The specialist indicated she would prescribe the drug as medication for Prader-Willi syndrome (PWS) to all eligible patients upon approval. Soleno Therapeutics' edge with the drug stems from the fact that other PWS treatments are in the early stages of development. Piper Sandler believes VYKAT XT represents significant potential as the first approved treatment specifically addressing PWS, a condition. The biotech company plans to file a Marketing Authorization Application for VYKAT XR in the second quarter. It's also pursuing regulatory approval in Europe as it plans to fill with the European Medicines agency. Following regulatory approvals, Soleno Therapeutics Palms will launch the drug in the first quarter of 2026. Soleno Therapeutics is a biopharmaceutical company that develops and commercializes novel treatments for rare diseases. Their lead product, diazoxide choline extended-release tablets (DCCR), is being developed for Prader-Willi syndrome (PWS), specifically to address hyperphagia (excessive hunger). While we acknowledge the potential of SLNO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Best Software Stocks to Buy Now and 11 Must-Buy AI Stocks Analysts Are Betting On. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Health care workers on alert for ICE raids in hospitals
President Trump's whittling away of protected places for immigrants has fueled fears among health care workers that Immigration and Customs Enforcement (ICE) agents will arrest patients in or around hospitals. In January, the Trump administration rescinded a Biden-era policy that protected certain areas like churches, schools and hospitals from immigration enforcement. And lawmakers in at least one state have introduced legislation aimed at making it easier for ICE to make arrests in hospitals. As the Department of Homeland Security (DHS) seeks to ramp up ICE raids at hotels, restaurants, farms and other sites, nurses worry their workplace could be next. 'We were all worried about what this meant,' Michael Kennedy, a nurse at a University of California, San Diego health facility located very near the U.S.-Mexico border, said of the policy changes under Trump. 'As we've seen these immigration raids ramp up, our first thought is about our patients and what that means for them.' ICE agents made a record number of migrant arrests in a single day this month and have appeared outside of courthouses in Seattle and stores in the New York City area. The agency's workplace raids in Los Angeles spurred days of protests, which in turn prompted a heavy-handed response from the Trump administration. Sandy Reding is a nurse at a hospital in Bakersfield, Calif., which serves communities of farm workers and employs a diverse staff. 'There is a lot of concern [about] ICE agents showing up with FBI or with the military, because we've seen a lot of reports on TV, and we have reports in our area where this is happening as well,' she said. Reding and her fellow nurses, she said, are also worried that the news of increased ICE raids will deter some patients from coming to the hospital to seek care. 'What we are going to see is a large burden on communities and hospitals if people delay care,' Reding said. 'And there are worse outcomes.' Nancy Hagan, an intensive care unit nurse at Maimonides Medical Center in New York City, said those concerns have come to fruition at her hospital. In May, she said, an immigrant New Yorker had appendicitis but waited too long to go to the emergency room. Their appendix burst, spreading infected tissue and bacteria to other organs, which ultimately killed them. 'Once patients hear that a hospital is no longer a safe place for them to go, they are afraid to come to the hospital,' she said. Hagan, a Haitian immigrant, added that she and her colleagues, who work at hospitals across the city, have noticed that emergency rooms appear to be emptier in recent months. Kennedy, the nurse in San Diego, said the Level 1 trauma center, which is typically packed, has been emptier than usual. He admitted the decline in patient visits could be seasonally related, but he said he believes that the possibility of ICE agents arresting immigrants is having a 'chilling effect.' 'I can't see how this doesn't affect our patients' willingness to seek care,' he said. 'I'm willing to bet that a lot of people are delaying care because they're afraid.' ICE did not get back to The Hill in response to questions on whether agents have arrested people in or around hospitals, or if there are plans to do so. DHS announced in January that it had rescinded former President Biden's guidelines on immigration enforcement at 'sensitive locations' that were first issued under former President Obama. 'The Trump Administration will not tie the hands of our brave law enforcement, and instead trusts them to use common sense,' a DHS spokesperson said at the time. The National Immigration Law Center said that while immigrants no longer have special protections at hospitals and other 'sensitive locations,' they still have basic rights. 'Instead, individuals will need to rely on basic constitutional protections in these spaces,' it said in a fact sheet. 'Specifically, the Fourth Amendment protects all individuals from unreasonable searches and seizures, and the Fifth Amendment ensures the right to remain silent when confronted by law enforcement.' The Emergency Medicine Residents' Association has distributed a flyer with step-by-step guidance for health care workers on dealing with ICE agents if they do enter hospitals. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Associated Press
2 hours ago
- Associated Press
The American Diabetes Association Announces Winners of the Innovation Challenge to Transform Diabetes Care
This challenge Kickstarts additional investments through the new ADA Innovation Fund CHICAGO, June 21, 2025 /PRNewswire/ -- As the American Diabetes Association® (ADA) celebrates its 85th anniversary, it continues to fuel transformative progress in the fight to end diabetes—and increasingly, obesity. This year's Innovation Challenge, held during the ADA's 85th Scientific Sessions, highlighted bold ideas driving the future of diabetes treatment and support. Five visionary finalists presented their innovations on the main stage before a panel of expert judges and a live audience. Three outstanding winners were selected for their potential to revolutionize diabetes care: Kihealth, MYNERVA, and Kayothera, INC. 'One of the biggest things we've learned in our 85 years is that in the fight to end diabetes, every new bit of knowledge, every advancement in treatment, every novel idea matters. We're proud to support these innovators as they help shape a future free of diabetes and all its burdens,' said Elle Uh, the ADA's chief strategy officer and chief of staff. This year's winners and finalists included: Winner: Kihealth—A diagnostic test to measure the rate of beta cell death through a liquid biopsy, providing patients and clinicians with a clear view of metabolic health and an earlier window into disease development. Winner: MYNERVA—An AI-driven neuroprosthetic smart sock for diabetes-related neuropathy to reduce pain and regain stability. Winner: Kayothera, INC—A first-in-class antagonist of the undruggable retinoid pathway to treat and potentially reverse type 2 diabetes. Finalist: BioDynamik, Inc.—An orthopedic-driven angiogenesis to restore perfusion for the healing of recalcitrant ischemic ulcers. Finalist: Generated Health—A chatbot combining AI-driven automation and human-like empathy with a simple text-based platform designed to support both patients and health care teams. The Innovation Challenge occurs at a critical time. Over 38 million Americans live with diabetes and about 125 million live with obesity. To meet these interconnected epidemics head-on, the ADA is launching the ADA Innovation Fund, a venture philanthropy fund designed to advance the ADA's mission by investing in innovative, high-impact companies developing diabetes, obesity, and other comorbidity-related solutions. Leveraging the ADA's 85-year history of funding hundreds of millions of dollars in innovative research grants, these investments aim to continue to accelerate mission-critical scientific breakthroughs, reduce health disparities, and promote sustainable health care solutions. About the ADA's Scientific Sessions The ADA's 85th Scientific Sessions, the world's largest scientific meeting focused on diabetes research, prevention, and care, will be held in Chicago, IL, on June 20–23. Thousands of leading physicians, scientists, and health care professionals from around the world are expected to convene both in person and virtually to unveil cutting-edge research, treatment recommendations, and advances toward a cure for diabetes. Attendees will receive exclusive access to thousands of original research presentations and take part in provocative and engaging exchanges with leading diabetes experts. Join the Scientific Sessions conversation on social media using #ADASciSessions. About the American Diabetes Association The American Diabetes Association (ADA) is the nation's leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure—and we're not stopping. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we're fighting for them all. To learn more or to get involved, visit us at or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook ( American Diabetes Association ), Spanish Facebook ( Asociación Americana de la Diabetes ), LinkedIn ( American Diabetes Association ), and Instagram ( @AmDiabetesAssn ). To learn more about how we are advocating for everyone affected by diabetes, visit us on X ( @AmDiabetesAssn ). View original content to download multimedia: SOURCE American Diabetes Association
